The Economic and Health Care Utilization Burden of Prior Authorization in Plastic and Reconstructive Surgery: A Scoping Review
BACKGROUND: Prior authorization (PA) is a utilization management strategy used by health insurers to control spending. Although PA requirements are widespread in plastic and reconstructive surgery, the economic and health care utilization consequences have not been systematically mapped. METHODS: A scoping review was conducted following PRISMA-ScR guidelines. PubMed/MEDLINE was searched systematically (2008 to 2026) using a primary combined query and a supplementary targeted query (together, 1015 and 413 unique records, respectively, re-verified live in September 2026); Embase, Web of Science, and Google Scholar were additionally searched using adapted terms as supplementary sources, though a structured, reproducible record count was not captured for these platforms. Data were extracted using a standardized charting form and synthesized narratively across 6 outcome domains. RESULTS: Twenty-nine studies met inclusion criteria. PA criteria for plastic surgery procedures varied dramatically across insurers and frequently contradicted clinical evidence. In the single study that modeled predictors of denial, insurer identity, not clinical factors, was the only independent predictor. Denial rates ranged from 9.3% to 72.7% depending on procedure and insurer. When appealed, 58% to 100% of denials were overturned. Administrative costs ranged from $15.11 per PA request to more than $68,000 per physician per year, with national PA-related administrative costs estimated at $93.3 billion annually across all stakeholders. Mapped evidence suggests PA did not reduce surgical volume for targeted plastic surgery procedures. Insurance-driven barriers disproportionately affected minority, low-income, and rural patients. CONCLUSIONS: PA in plastic and reconstructive surgery imposes substantial economic and administrative costs without demonstrating reduction in unnecessary care. The mapped evidence suggests PA shifts costs downstream rather than reducing them. Evidence-based policy reform, including gold carding and standardized authorization criteria, may improve value without compromising cost containment.
Authors
- Michelle Yoon (ORCID: https://orcid.org/0009-0005-9617-1393)
- Peter W. Henderson (ORCID: https://orcid.org/0000-0002-8392-7180)
- Sheuli Chowdhury
- Ross Jacobson (ORCID: https://orcid.org/0009-0003-5302-0099)
- Francesca Jareis
Institutions
- Dartmouth College (US)
- University of Vermont (US)
- Tulane University (US)
- Georgetown University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Annals of Plastic Surgery
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1097/sap.0000000000004934
- Primary Topic
- Healthcare Policy and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00